Measles (Rubeola) Antibody, IgG
Also known as: MEASLES G
Use
The Measles (Rubeola) Antibody, IgG test is used to determine the presence of IgG antibodies against the measles virus. It is primarily used to confirm immunity to measles, typically as a result of prior vaccination or past infection. A positive result indicates a current or past exposure to measles or successful immunization. It can be utilized in situations where there is a need to verify immunization status, especially in individuals who require evidence of immunity due to travel, employment, or school entry requirements.
Special Instructions
For cerebrospinal fluid, order Measles (Rubeola) Antibody, IgG, CSF (0054440). Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Limitations
The test is not recommended as a stand-alone test except for determining antibody production from vaccination. A negative result does not rule out susceptibility to measles, especially if testing occurred shortly after exposure. Test sensitivity and specificity might be affected by the timing of specimen collection relative to infection or vaccination. IgG levels may not correlate with protective immunity in some individuals.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 7962-4
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Serum separator tube (SST)
Collection Instructions
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated.
Causes for Rejection
Contaminated, heat-inactivated, grossly hemolyzed, lipemic or severely icteric specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year (avoid repeated freeze/thaw cycles) |